Company news

Belite Bio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1

October 14, 2026

Decks

The 5 newest of 17 decks. Every deck is listed under its year.